Distinguiti per questo ruolo — genera un curriculum personalizzato e una lettera di presentazione in circa un minuto.
Regeneron Italy S.r.l. seeks a Sales Manager Immunology Commercial Leadership for the Centro-Sud region. You will lead Sales Specialists, drive targets, and collaborate with HR and Commercial Operations in a hybrid work model, with frequent travel across the Centro-Sud area.
The role requires a Bachelor’s degree and 7+ years of pharmaceutical account management experience, with strong leadership, budgeting, and strategic planning capabilities. Dermatology knowledge is a plus.
Build our future together: At Regeneron, we use science and innovation to develop life-changing medicines for people with serious diseases. We are seeking a Sales Manager Immunology Commercial Leadership Centro-Sud to join our commercial team, supporting our Centro-Sud business area in a hybrid work model. In this role, you will lead Sales Specialists to deliver commercial goals while collaborating with Human Resources, Commercial Operations, and our co-commercialization partner. This position offers the opportunity to contribute to a fast-growing, science-driven organization making a meaningful difference to patients worldwide.
Region: Centro-Sud
Work model: Hybrid
Frequent travel required.
We are committed to building a workplace with an inclusive culture. Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex, sexual orientation, gender identity or expression, gender reassignment, marital or civil partnership status, civil status, pregnancy or parental status, age, disability, nationality, citizenship status, ethnic or national origin, membership of the Traveler community, familial status, genetic information, military or veteran status, or any other characteristic protected under applicable law. Where required, we will provide reasonable accommodation to applicants with known disabilities or chronic illnesses during the recruitment process, unless such accommodation would impose undue hardship.
Regeneron offers a competitive and comprehensive total rewards package which may include, depending on country and role:
For additional information about Regeneron benefits in the U.S., please visit https://careers.regeneron.com/en/working-at-regeneron/total-rewards/. For other locations, additional information will be provided during the recruitment process.
If you have any questions, please speak with your recruiter.
Please be advised that at Regeneron, we believe we do our best work when we are together. For that reason, many roles are required to be performed on‑site. Please speak with your recruiter and hiring manager for more information about on‑site expectations for your role and location.
As part of the recruitment process, certain background checks may be conducted in accordance with the laws of the country where the position is based. The purpose of such checks is to verify certain information prior to the commencement of employment such as identity, right to work and educational qualifications.
For jobs in Canada: this posting is for an existing position. Salary Range (annually) €78,150.00 - €130,250.00
Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurology, infectious diseases and rare diseases.
Regeneron is also proud of award winning culture of innovation, being recognized as a Great Place to Work in 2021, Fast Company’s Best Workplace for Innovators in 2020, and Forbes JUST companies in 2020, among others.